Search
Artificial intelligence successfully predicts protein interactions: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/artificial-intelligence-successfully-predicts-protein-interactions.html
UT Southwestern and University of Washington researchers led an international team that used artificial intelligence (AI) and evolutionary analysis to produce 3D models of eukaryotic protein interactions.
UTSW researchers show effectiveness of migraine drug in weight loss: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-migraine-drug-in-weight-loss.html
Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests.
Experimental drug could spur immunotherapy response in patients with non-small cell lung cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/non-small-cell-lung-cancer.html
Research led by UT Southwestern scientists suggests that an investigational drug could restore the ability of some non-small cell lung cancers (NSCLCs) to respond to an immune checkpoint blockade (ICB), a therapy that harnesses the immune system to fight malignant tumors.
UTSW findings advance RAS inhibitors for use in fighting more cancers: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/ras-inhibitors-for-use-in-fighting-more-cancers.html
New findings by UT Southwestern researchers help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease.
UT Southwestern’s Inaugural Chair of Biomedical Engineering elected to National Academy of Medicine: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/inaugural-chair-of-biomedical-engineering-nam.html
Samuel Achilefu, Ph.D., the incoming Inaugural Chair of UT Southwestern Medical Center’s new Department of Biomedical Engineering, is among 100 members elected to the National Academy of Medicine (NAM) this year.
UT Southwestern Medical School ranked among nation’s best in research, primary care by U.S. News & World Report: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/us-news-world-report-patient-care.html
UT Southwestern is ranked among the top 20 medical schools for primary care and the top 25 for research in the United States, according to U.S. News & World Report’s 2023 Best Graduate Schools rankings.
UTSW leads nation’s first study of brief suicide intervention for LGBTQ+ young adults : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/suicide-intervention-for-lgbtq-young-adults.html
UT Southwestern Medical Center will lead the nation’s first study of suicide prevention for LGBTQ+ young adults – a group at higher risk for depression and suicide.
UTSW scientists reveal how vitamin A enters immune cells in the gut: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/how-vitamin-a-enters-immune-cells-in-the-gut.html
Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.
UTSW is a founding member of new sickle cell clinical trials network: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-sickle-cell-clinical-trials-network.html
In a move that will increase access and efficiency of clinical trials for patients with sickle cell disease.
UTSW researchers identify first Beta variant in North Texas amid rise of "variants of concern": Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/first-beta-variant-in-north-texas.html
UT Southwestern Medical Center scientists have identified the first two cases of the Beta variant (B.1.351) of COVID-19 infection in North Texas using next-generation sequencing technologies along with targeted PCR testing.